These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 202135)

  • 21. 30 Min ACTH stimulation test as predictor of hypothalamic-pituitary-adrenocortical function. Comparison with metyrapone test.
    Blichert-Toft M; Lindholm J; Kehlet H
    Acta Med Scand; 1980; 207(1-2):115-7. PubMed ID: 6245561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothalamic-pituitary-adrenal axis.
    Honour JW
    Respir Med; 1994 Aug; 88 Suppl A():9-13; discussion 13-5. PubMed ID: 7972994
    [No Abstract]   [Full Text] [Related]  

  • 23. The recovery of the hypothalamo-pituitary-adrenal axis after transsphenoidal operation in three patients with Cushing's disease. The effect of prior external pituitary irradiation.
    Lamberts SW; Klijn GM; de Jong JG; Birkenhäger JC
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):580-5. PubMed ID: 6272518
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypothalamo-pituitary-adrenocortical function in rats with inherited diabetes insipidus.
    Buckingham JC; Leach JH
    J Physiol; 1980 Aug; 305():397-404. PubMed ID: 6255146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults: results from a prospective randomized multicenter study.
    Hamrahian AH; Yuen KC; Gordon MB; Pulaski-Liebert KJ; Bena J; Biller BM
    Pituitary; 2016 Jun; 19(3):332-41. PubMed ID: 26897383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The hypothalamic-pituitary-adrenal axis in anorexia nervosa and bulimia nervosa: pathophysiologic implications.
    Laue L; Gold PW; Richmond A; Chrousos GP
    Adv Pediatr; 1991; 38():287-316. PubMed ID: 1656715
    [No Abstract]   [Full Text] [Related]  

  • 27. Dehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axis.
    Fischli S; Jenni S; Allemann S; Zwahlen M; Diem P; Christ ER; Stettler C
    J Clin Endocrinol Metab; 2008 Feb; 93(2):539-42. PubMed ID: 17986637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of the hypothalamo-pituitary-adrenal axis and duration of diabetes.
    Roy M; Collier B; Roy A
    J Diabet Complications; 1991; 5(4):218-20. PubMed ID: 1663954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the short ACTH stimulation test with the insulin tolerance/glucagon test.
    Stewart PM; Clark PM; Sheppard MC
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):124-6. PubMed ID: 9509080
    [No Abstract]   [Full Text] [Related]  

  • 30. [The hypothalamo-pituitary-adrenal system in thyroid dysfunction (author's transl)].
    Kawagoe M
    Nihon Naibunpi Gakkai Zasshi; 1977 Aug; 53(8):1004-21. PubMed ID: 199482
    [No Abstract]   [Full Text] [Related]  

  • 31. [Correlations between the hypothalamo-pituitary-adrenal axis and the metabolic syndrome].
    Góth M; Hubina E; Korbonits M
    Orv Hetil; 2005 Jan; 146(2):51-5. PubMed ID: 15724952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered hypothalamic-pituitary-adrenal axis activity in patients with chronic heart failure.
    Sivukhina EV; Poskrebysheva AS; Smurova IuV; Dolzhikov AA; Morozov IuE; Jirikowski GF; Grinevich V
    Horm Metab Res; 2009 Oct; 41(10):778-84. PubMed ID: 19544245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical significance of the diagnostic use and assay of corticotropin-releasing hormone in the physiopathologic state of the hypothalamo-pituitary-adrenal axis].
    Nishikawa T; Yoshida A; Mikami K; Tamura Y; Yoshida S
    Nihon Rinsho; 1990 Feb; 48 Suppl():182-4. PubMed ID: 2162415
    [No Abstract]   [Full Text] [Related]  

  • 34. Congenital optic nerve hypoplasia with hypothalamic-pituitary dysplasia. A review of 16 cases.
    Margalith D; Tze WJ; Jan JE
    Am J Dis Child; 1985 Apr; 139(4):361-6. PubMed ID: 3976626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothalamic-pituitary-adrenal axis dysfunction in non-clinical psychosis.
    Mittal VA; Orr JM; Pelletier A; Dean DJ; Smith A; Lunsford-Avery J
    Psychiatry Res; 2013 Apr; 206(2-3):315-7. PubMed ID: 23332683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma-cortisol response to lysine-vasopressin. Comparison with other tests of human pituitary-adrenocortical function.
    Landon J; James VH; Stoker DJ
    Lancet; 1965 Dec; 2(7423):1156-9. PubMed ID: 4158910
    [No Abstract]   [Full Text] [Related]  

  • 37. Cortisol response to vasopressin in depression.
    Krahn DD; Meller WH; Shafer RB; Morley JE
    Biol Psychiatry; 1985 Aug; 20(8):918-21. PubMed ID: 2992617
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessing the hypothalamo-pituitary-adrenocortical axis using physiological doses of adrenocorticotropic hormone.
    Talwar V; Lodha S; Dash RJ
    QJM; 1998 Apr; 91(4):285-90. PubMed ID: 9666951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Corticotropin releasing factor (CRF)-stimulating test in patients with disorders of the hypothalamo-pituitary-adrenal axis].
    Hashimoto K; Murakami K; Hattore T; Ota Z
    Nihon Naika Gakkai Zasshi; 1984 Sep; 73(9):1317-24. PubMed ID: 6097622
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypothalamic sarcoidosis and hypopituitarism.
    Jawadi MH; Hanson TJ; Schemmel JE; Beck P; Katz FH
    Horm Res; 1980; 12(1):1-9. PubMed ID: 6245023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.